Teresa Zuverino Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 315 Earth Bridge Rd, Putney, VT 05346 Phone: 802-490-6904 |
Jessica L Taylor, MA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 40 Leon Wood Rd, Putney, VT 05346 Phone: 802-451-6706 |
Ms. Penny Simpson Adams Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 114 Westminster Rd, Putney, VT 05346 Phone: 802-387-8548 Fax: 802-387-2550 |
Jon Schottland, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 61 Parkman Wood Rd, Putney, VT 05346 Phone: 802-387-4827 |
Katelyn Mulford O'connor, LCMHC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 418 Houghton Brook Rd, Putney, VT 05346 Phone: 413-530-5404 |
Barry Shaw, LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 94 Main Street, Putney, VT 05346 Phone: 802-387-6077 Fax: 802-387-6077 |
Ms. Katharine Barrington Nephew King, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 125 Joy Rd, Putney, VT 05346 Phone: 781-859-8200 |
Mr. William Scarlett Iv, LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 133 Main St, Putney, VT 05346 Phone: 802-376-6317 |
News Archive
The products of Titertek-Berthold / Berthold Detection Systems GmbH and the life science business of Berthold Technologies GmbH & Co. KG ("Bioanalytic") have been trusted by scientists in basic research, pharmaceutical, biomedical and applied markets laboratories across the globe for more than half a century.
Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found that convalescent plasma therapy was associated with the emergence of viral variants that were less susceptible to neutralizing antibodies.
Emergency medicine physicians at Temple University Hospital have found that an opioid prescribing guideline had an immediate and sustained impact on opioid prescribing rates for minor conditions and chronic noncancer pain in an acute care setting.
Sanofi-aventis announced today that Health Canada has granted market authorization for Jevtana injection in combination with prednisone for the treatment of patients with metastatic castration resistant prostate cancer, previously treated with a docetaxel-containing treatment regimen.
› Verified 6 days ago